Oxidative Stress and Precision Medicine in Cardiometabolic and Cardiovascular Disease: Mechanisms, Biomarkers, and Therapeutic Targets

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 31 May 2026 | Viewed by 1435

Special Issue Editors


E-Mail Website
Guest Editor
Young Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Interests: biomarker discovery; quantitiative liquid chromatography–mass spectrometry; cardiovascular disease; chronic diseases; oxidative stress

E-Mail Website
Guest Editor
Cardiovascular Research Institute, Young Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Interests: biomarker discovery; liquid chromatography-mass spectrometry; nanoparticles; cardiovascular disease; biostatistics; oxidative stress
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are pleased to announce the new edition of our Special Issue “Oxidative Stress and Precision Medicine in Cardiometabolic and Cardiovascular Disease: Mechanisms, Biomarkers, and Therapeutic Targets”.

Cardiometabolic and cardiovascular diseases, including atherosclerosis, diabetes, obesity, hypertension, and heart failure, remain major global causes of morbidity and mortality. Increasing evidence indicates that oxidative stress, mitochondrial dysfunction, and disrupted redox signaling are fundamental drivers of vascular injury, metabolic dysregulation, and inflammation. These processes promote endothelial dysfunction, lipid peroxidation, and apoptotic injury, contributing to both metabolic and cardiovascular pathologies. Despite decades of research, translating antioxidants from redox science into clinical applications remains limited, underscoring the urgent need for mechanistic insight and precision biomarker discovery.

This Special Issue of Antioxidants focuses on oxidative stress, redox omics, and precision cardiometabolic medicine. We invite original research and reviews that cover the following:

  • Explore molecular and cellular mechanisms linking oxidative and nitrosative stress to cardiometabolic dysfunction.
  • Identify or validate novel redox biomarkers through mass spectrometry, metabolomics, lipidomics, or proteomics.
  • Investigate therapeutic targets or redox modulating interventions for cardiometabolic and cardiovascular diseases.

Submissions employing artificial intelligence (AI), machine learning, or systems biology to advance biomarker discovery, predictive modelling, and personalized therapeutic strategies are particularly encouraged. Translational and clinical studies evaluating antioxidant therapies, redox modulators, or dietary/pharmacological approaches are also highly relevant.

By integrating mechanistic redox biology, precision diagnostics, and computational analytics, this Special issue aims to accelerate the development of AI-enabled, biomarker-driven antioxidant therapies and advance precision medicine for cardiometabolic and cardiovascular health.

We warmly invite your valuable contributions to this Special Issue.

Dr. Leroy Sivappiragasam Pakkiri
Dr. Chester Lee Drum
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxidative stress
  • precision medicine
  • cardiometabolic disease
  • cardiovascular disease
  • redox signaling

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 4975 KB  
Review
Redox-Driven Precision Medicine for Life-Course Prevention of Cardiovascular–Kidney–Metabolic Syndrome
by Chien-Ning Hsu and You-Lin Tain
Antioxidants 2026, 15(2), 221; https://doi.org/10.3390/antiox15020221 - 8 Feb 2026
Viewed by 1109
Abstract
Accumulating evidence recognizes cardiovascular–kidney–metabolic syndrome (CKMS) as a life-course disorder arising from dynamic and maladaptive interactions among the heart, vasculature, kidneys, liver, and pancreas. Beyond a late-onset clinical entity, CKMS susceptibility is increasingly understood to be programmed during critical developmental periods. Redox imbalance [...] Read more.
Accumulating evidence recognizes cardiovascular–kidney–metabolic syndrome (CKMS) as a life-course disorder arising from dynamic and maladaptive interactions among the heart, vasculature, kidneys, liver, and pancreas. Beyond a late-onset clinical entity, CKMS susceptibility is increasingly understood to be programmed during critical developmental periods. Redox imbalance has emerged as a central integrative mechanism in this process, functioning as a mechanistic interface through which adverse early-life environments translate into persistent multi-organ vulnerability. Perturbation of the reactive oxygen species–nitric oxide axis during development disrupts organogenesis, vascular maturation, and metabolic regulation, resulting in enduring structural and functional alterations that predispose individuals to hypertension, metabolic dysfunction, and chronic kidney disease. These insights position redox biology not merely as a pathogenic mechanism but as a strategic entry point for precision intervention. Addressing the escalating global burden of CKMS requires a paradigm shift toward redox-driven precision medicine. This framework integrates biologically informed phenotyping, life-course–based risk stratification, early precision prevention through developmental reprogramming, and phenotype-guided therapeutics to stabilize interconnected organ networks. Transitioning from reactive, fragmented care to a proactive, systems-oriented approach offers a transformative opportunity to interrupt intergenerational risk transmission and achieve durable improvements in cardiovascular–kidney–metabolic health across the lifespan. Full article
Show Figures

Figure 1

Back to TopTop